O
OrbiMed’s Aclaris Therapeutics ACRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-2,758,434
| Closed | -$43.4M | – | 117 |
|
2022
Q4 | $43.4M | Hold |
2,758,434
| – | – | 0.83% | 45 |
|
2022
Q3 | $43.4K | Buy |
2,758,434
+432,934
| +19% | +$6.81K | 0.81% | 46 |
|
2022
Q2 | $32.5K | Buy |
2,325,500
+745,600
| +47% | +$10.4K | 0.59% | 54 |
|
2022
Q1 | $27.2M | Buy |
1,579,900
+594,000
| +60% | +$10.2M | 0.44% | 57 |
|
2021
Q4 | $14.3M | Buy |
985,900
+334,117
| +51% | +$4.86M | 0.18% | 101 |
|
2021
Q3 | $11.7M | Buy |
651,783
+289,783
| +80% | +$5.22M | 0.13% | 119 |
|
2021
Q2 | $6.36M | Buy |
+362,000
| New | +$6.36M | 0.06% | 140 |
|